These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Influence of Resveratrol on the Cardiovascular Health Effects of Chronic Kidney Disease. Song JY; Shen TC; Hou YC; Chang JF; Lu CL; Liu WC; Chen PJ; Chen BH; Zheng CM; Lu KC Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878067 [TBL] [Abstract][Full Text] [Related]
26. Uremic Toxin-Targeting as a Therapeutic Strategy for Preventing Cardiorenal Syndrome. Taguchi K; Elias BC; Brooks CR; Ueda S; Fukami K Circ J; 2019 Dec; 84(1):2-8. PubMed ID: 31827008 [TBL] [Abstract][Full Text] [Related]
27. Microbiota and the nitrogen cycle: Implications in the development and progression of CVD and CKD. Briskey D; Tucker PS; Johnson DW; Coombes JS Nitric Oxide; 2016 Jul; 57():64-70. PubMed ID: 27164294 [TBL] [Abstract][Full Text] [Related]
28. Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease. Li DY; Tang WHW Semin Nephrol; 2018 Mar; 38(2):193-205. PubMed ID: 29602401 [TBL] [Abstract][Full Text] [Related]
29. [Trimethylamine-N-oxide and cardiovascular events in chronic kidney disease]. Dai Q; Zhang H; Liu Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Nov; 44(11):1294-1299. PubMed ID: 31919326 [TBL] [Abstract][Full Text] [Related]
31. Toxic Effects of Indoxyl Sulfate on Osteoclastogenesis and Osteoblastogenesis. Shyu JF; Liu WC; Zheng CM; Fang TC; Hou YC; Chang CT; Liao TY; Chen YC; Lu KC Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681927 [TBL] [Abstract][Full Text] [Related]
32. Chronic Kidney Disease and Cardiovascular Disease: Is there Any Relationship? Vallianou NG; Mitesh S; Gkogkou A; Geladari E Curr Cardiol Rev; 2019; 15(1):55-63. PubMed ID: 29992892 [TBL] [Abstract][Full Text] [Related]
33. Pro-Arrhythmic Potential of Accumulated Uremic Toxins Is Mediated via Vulnerability of Action Potential Repolarization. van Ham WB; Cornelissen CM; Polyakova E; van der Voorn SM; Ligtermoet ML; Monshouwer-Kloots J; Vos MA; Bossu A; van Rooij E; van der Heyden MAG; van Veen TAB Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982449 [TBL] [Abstract][Full Text] [Related]
37. The role of lipids and uremic toxins in cardiovascular disease in CKD. Massy ZA Clin Exp Nephrol; 2014 Apr; 18(2):255-6. PubMed ID: 24072415 [TBL] [Abstract][Full Text] [Related]
38. Female AhR Knockout Mice Develop a Minor Renal Insufficiency in an Adenine-Diet Model of Chronic Kidney Disease. Makhloufi C; Nicolas F; McKay N; Fernandez S; Hache G; Garrigue P; Brunet P; Guillet B; Burtey S; Poitevin S Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260098 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach. Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122 [TBL] [Abstract][Full Text] [Related]
40. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease. Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]